FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel compounds that are partial and complete agonists of adenosine A1 receptors of the formula (1): 
wherein R1 means cyclopentyl, cyclohexyl or tetrahydrofuranyl optionally substituted with hydroxy-group or -CO2CH2CH3; R2 means hydrogen atom; R3 means phenyl, isoxazole, thiophenyl or thiazolyl substituted optionally with one or more substitutes chosen from group comprising methyl, methoxy- group, fluorine atom and chlorine atom; R4 and R5 mean hydrogen atom; T means a covalent bond or methylene group; X means covalent bond; Y means -O-, -NH- or covalent bond; Z means alkylene group comprising of 1-3 carbon atoms. Proposed compounds can be used in treatment of different morbid states, in particular, tachycardia and atrium tremor, stenocardia, myocardium infarction and hyperlipidemia, and to a pharmaceutical composition based on these compounds.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
22 cl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PARTIAL AND FULL AGONISTS OF ADENOSINE RECEPTORS A | 2003 |
|
RU2340623C2 |
| AGONISTS OF ADENOSINE A3-RECEPTORS | 2002 |
|
RU2298557C2 |
| METHODS AND COMPOSITIONS IMPROVING PATIENT'S TOLERANCE OF MYOCARDIAL VISUALISATION TECHNIQUE | 2007 |
|
RU2459626C2 |
| METHODS OF HEARTBEAT FREQUENCY REDUCTION INCLUDING ADMINISTRATION OF ADENOSINE A RECEPTOR AGONIST TOGETHER WITH BETA-BLOCKER, CALCIUM CANAL BLOCKER OR CARDIAC GLYCOSIDE | 2003 |
|
RU2332220C2 |
| DERIVATIVES OF ADENOSINE, PHARMACEUTICAL COMPOSITION AND METHOD OF CORRECTION OF ELECTRIC DISORDER IN MAMMAL HEART | 1997 |
|
RU2172320C2 |
| PHOSPHORUS(N)AMIDATEACETAL AND PHOSPH(OH)ATACETAL COMPOUNDS | 2019 |
|
RU2796403C2 |
| SUBSTITUTED (2R,3R,5R)-3-HYDROXY-(5-PYRIMIDIN-1-YL)TETRAHYDROFURAN-2-YLMETHYL ARYL PHOSPHORAMIDATES | 2013 |
|
RU2553996C1 |
| THERAPEUTIC COMPOUNDS | 2007 |
|
RU2441875C2 |
| SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
| TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
